Site logo
Site logo
Mobile logo
  • Home
  • About
  • NYC TMS Services
  • NYC Spravato Services
  • Insurance Coverage
  • FAQs
  • Blog
  • Contact

esketamine

Depression A doctor and patient engage in a friendly conversation about esketamine as a glutamate depression treatment
January 14, 2026in Depression 0 Comments 0 Likes

How Esketamine as a Glutamate Depression Treatment is Changing the Landscape of MDD

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, affecting more than 280 million people. While traditional antidepressants have helped millions, about one-third of people with

by Dr. Bryan Bruno, Medical Director
Depression Shot of a young couple spending time together at the beach, demonstrating how ketamine can improve quality of life for people with Depression
July 15, 2025in Depression 0 Comments 0 Likes

Does Ketamine Improve Quality of Life for People with Depression?

When you hear the word “ketamine,” you might think of club drugs or even anesthesia. But in recent years, ketamine—and its close cousin, esketamine (Spravato)—has been receiving much attention in

by Dr. Bryan Bruno, Medical Director

Recent Posts

  • Non-Invasive Depression Treatment Options NYC: TMS Avoids Antidepressant Side Effects
  • How TMS Can Reduce Patient Irritability in Depression
  • Psilocybin Therapy NYC: Why TMS and Spravato Remain Better Treatment Options
  • Precision, Not Price: Effective TMS Coil Placement Doesn’t Require MRI Guidance
  • How Esketamine as a Glutamate Depression Treatment is Changing the Landscape of MDD

Categories

  • anxiety
  • COVID-19
  • Depression
  • Depression Factors
  • Loneliness
  • Manhattan TMS
  • Resources
  • Support
  • TMS
  • TMS Maintenance
  • Treatment
  • Types of Depression
  • Uncategorized
Site Map
  • Home
  • About
  • Services
  • Insurance Coverage
  • Frequently Asked Questions
  • Blog
Copyright © 2024 Mid City TMS. All rights reserved. Designed by Online Optimism.
280 Madison Ave, Suite 1102, New York, NY 10016
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 650px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}